Breast and Gynecologic Cancers

Expert faculty review and share their insights and perspectives on key findings in breast and gynecologic cancers presented at the 2020 ASCO Annual Meeting.

Share

Program Content

Activities

  • ASCO 2020 Breast/Gyn
    Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting
    Conference Coverage
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 09, 2020

    Expires: September 08, 2021

  • <i>EP</i>: Breast and GYN
    ExpressPoints: Key Studies in Breast and Gynecologic Cancers
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 09, 2020

    Expires: September 08, 2021

Activities

KEYNOTE-355 Safety + Efficacy
KEYNOTE-355: Pembrolizumab + Chemotherapy for Previously Untreated Advanced Triple-Negative Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

SWOG 1416: Plt Plus PARPi
Phase II SWOG 1416: Cisplatin Plus Veliparib or Placebo in Metastatic TNBC and BRCA Mutation–Associated Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

HER2CLIMB CNS Analysis
HER2CLIMB: Tucatinib Plus Trastuzumab and Capecitabine in Previously Treated HER2-Positive MBC With Brain Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2020

Expires: June 01, 2021

BYLieve: Alpelisib After CDK4/6i
Phase II BYLieve: Alpelisib Plus Fulvestrant in PIK3CA-Mutated HR+/HER2- Advanced Breast Cancer After CDK4/6 Inhibitor Plus AI
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

MONALEESA Pooled Analysis
Biomarkers of Response or Resistance to Ribociclib + Endocrine Therapy for Advanced Breast Cancer: Pooled Analysis of MONALEESA Phase III Trials
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2020

Expires: May 30, 2021

MONALEESA-3/-7 Pooled
MONALEESA-3/-7 Pooled OS Analysis: Ribociclib Plus ET in Patients With HR+/HER2- Advanced Breast Cancer and Visceral Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

CompLEEment-1
CompLEEment-1: Updated Results From the Phase IIIb Study of Ribociclib Plus Letrozole in HR+, HER2- Advanced Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

DESKTOP III: Surgery in PSROC
DESKTOP III: Improved Survival With Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

SOLO2 Final OS Analysis
SOLO2: Final OS Analysis of Maintenance Olaparib in Platinum-Sensitive, Relapsed Ovarian Cancer with BRCA Mutation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

KEYNOTE-100
KEYNOTE-100: Final Results From Phase II Study on Pembrolizumab Monotherapy for Advanced Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2020

Expires: June 07, 2021

AVANOVA2 Update
AVANOVA2 Extended Follow-up: Niraparib Plus Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2020

Expires: June 07, 2021

Niraparib Dosing
Optimal Dosing of the Poly(ADP-Ribose) Polymerase Inhibitor Niraparib
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

Lenvatinib/Pembrolizumab
KEYNOTE-146: Lenvatinib Plus Pembrolizumab as Early-Line Treatment of Advanced Endometrial Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

E2108: Local Tx in de novo MBC
ECOG-ACRIN 2108: Phase III Trial Evaluating the Role of Early Local Therapy for Patients With Metastatic Breast Cancer and an Intact Primary Tumor
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2020

Expires: June 08, 2021

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation